Cogent Biosciences, Inc. (COGT)

34.51 +0.57 (+1.68%) USD  |  NASDAQ  |  May 27, 16:00
34.54 +0.03 (+0.09%) After-Hours: 20:00
More

Cogent Biosciences Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Syndax Pharmaceuticals, Inc. Upgrade
Vera Therapeutics, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade